Cargando…

Getting hands on a drug for Covid-19: Inhaled and Intranasal Niclosamide

Detalles Bibliográficos
Autor principal:	Kunzelmann, Karl
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041586/ https://www.ncbi.nlm.nih.gov/pubmed/33870260 http://dx.doi.org/10.1016/j.lanepe.2021.100094

Ejemplares similares

A randomized, double-blind, placebo-controlled phase 1 trial of inhaled and intranasal niclosamide: A broad spectrum antiviral candidate for treatment of COVID-19
por: Backer, Vibeke, et al.
Publicado: (2021)

Airway Delivery of Hydrogel-Encapsulated Niclosamide for the Treatment of Inflammatory Airway Disease
por: Ousingsawat, Jiraporn, et al.
Publicado: (2022)

Niclosamide: Beyond an antihelminthic drug
por: Chen, Wei, et al.
Publicado: (2018)

Niclosamide for Covid-19: bridging the gap
por: Al-kuraishy, Hayder M., et al.
Publicado: (2021)

Niclosamide—A promising treatment for COVID‐19
por: Singh, Shivani, et al.
Publicado: (2022)

Inhalable antibodies for the treatment of COVID-19
por: Yang, Zhenlin, et al.
Publicado: (2022)

Commentary: Care for retinopathy of prematurity in the COVID-19 era: When the going gets tough, the tough get going
por: Sen, Parveen, et al.
Publicado: (2022)

Will refugees also get vaccinated against COVID-19 in Africa?
por: Ibrahim, Abdulmumin Damilola, et al.
Publicado: (2021)

The subtle nuances of intranasal corticosteroids
por: Fowler, James, et al.
Publicado: (2021)

Sterilization plan of the used metered dose inhalers (MDI) to avoid wastage amid COVID-19 pandemic drug shortage
por: Elbeddini, Ali
Publicado: (2020)

Thrombosis with COVID-19: kids get it too
por: Takemoto, Cliff
Publicado: (2021)

Repurposing the anthelmintic drug niclosamide to combat Helicobacter pylori
por: Tharmalingam, Nagendran, et al.
Publicado: (2018)

Drug Repurposing: The Anthelmintics Niclosamide and Nitazoxanide Are Potent TMEM16A Antagonists That Fully Bronchodilate Airways
por: Miner, Kent, et al.
Publicado: (2019)

Plausible mechanisms of Niclosamide as an antiviral agent against COVID-19
por: Pindiprolu, Sai Kiran S.S., et al.
Publicado: (2020)

The magic bullet: Niclosamide
por: Jiang, Haowen, et al.
Publicado: (2022)

Robots do not get the coronavirus: The COVID-19 pandemic and the international division of labor
por: Brakman, Steven, et al.
Publicado: (2021)

The scourge of substandard and falsified medical products gets worse with COVID-19 pandemic
por: Shiferie, Fisseha, et al.
Publicado: (2020)

Standardized inhalation capability assessment: A key to optimal inhaler selection for inhalation therapy
por: Wu, Yixing, et al.
Publicado: (2023)

In Vitro Evaluation and Mitigation of Niclosamide’s Liabilities as a COVID-19 Treatment
por: Wotring, Jesse W., et al.
Publicado: (2022)

In Vitro Evaluation and Mitigation of Niclosamide’s Liabilities as a COVID-19 Treatment
por: Wotring, Jesse W., et al.
Publicado: (2022)

Amid COVID-19 drug shortages: proposed plan for reprocessing and reusing salbutamol pressurized metered dose inhalers (pMDIs) for shared use
por: Elbeddini, Ali, et al.
Publicado: (2020)

Drug Repurposing of the Anthelmintic Niclosamide to Treat Multidrug-Resistant Leukemia
por: Hamdoun, Sami, et al.
Publicado: (2017)

Equity in HTA: what doesn’t get measured, gets marginalised
por: Cookson, Richard, et al.
Publicado: (2017)

Target Drug Exposure Attainment in Children: How to Get from Better to Best
por: Flint, Robert B., et al.
Publicado: (2020)

Niclosamide inhalation powder made by thin-film freezing: Multi-dose tolerability and exposure in rats and pharmacokinetics in hamsters
por: Jara, Miguel O., et al.
Publicado: (2021)

Get comfortable with being uncomfortable: Experiences from diagnostic radiographers a year into the COVID-19 pandemic
por: Tay, Yi Xiang, et al.
Publicado: (2021)

Inhaled prostacyclin analogues in COVID-19 associated acute respiratory distress syndrome: scientific rationale
por: Mulia, Eka Prasetya Budi, et al.
Publicado: (2021)

Getting Ahead of the Virus
por: Hatchett, Richard
Publicado: (2021)

Getting into the thick (and thin) of it
por: Irving, Thomas C., et al.
Publicado: (2019)

RNA gets in phase
por: Saha, Shambaditya, et al.
Publicado: (2017)

Commentary: Get your hairdresser's visual needs right to get your hairstyle right!
por: Hussaindeen, Jameel Rizwana
Publicado: (2021)

‘What gets measured gets managed’: revisiting the indicators for maternal and newborn health programmes
por: Moran, A. C., et al.
Publicado: (2018)

Artificial intelligence and clinical data suggest the T cell-mediated SARS-CoV-2 nonstructural protein intranasal vaccines for global COVID-19 immunity
por: Seyran, Murat
Publicado: (2022)

Getting to the Guts of HIV Pathogenesis
por: Veazey, Ronald S., et al.
Publicado: (2004)

Getting older can be exhausting
por: Mittal, Rohit, et al.
Publicado: (2014)

Getting rigorous with scientific rigor
por: Hofseth, Lorne J
Publicado: (2018)

“Get to Know Me” Board
por: Gajic, Ognjen, et al.
Publicado: (2019)

Getting old beats the alternative
por: Kessler, Allison
Publicado: (2022)

Commentary: Getting circulations crossed!
por: Cleveland, John D., et al.
Publicado: (2020)

Commentary: Getting off the DESK!
por: Chaturvedi, Isha, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f7im50ko5mgm9nsfark0u3637k